Alaunos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
TCRT Key Statistics
Stock Snapshot
Alaunos Therapeutics(TCRT) stock is priced at $2.88, giving the company a market capitalization of 7.14M. It carries a P/E multiple of -1.16.
On 2026-05-06, Alaunos Therapeutics(TCRT) stock traded between a low of $2.60 and a high of $2.89. Shares are currently priced at $2.88, which is +10.8% above the low and -0.2% below the high.
The Alaunos Therapeutics(TCRT)'s current trading volume is 14.29K, compared to an average daily volume of 11.46K.
During the past year, Alaunos Therapeutics(TCRT) stock moved between $1.67 at its lowest and $6.20 at its peak.
During the past year, Alaunos Therapeutics(TCRT) stock moved between $1.67 at its lowest and $6.20 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.